NPFFR2 Contributes to the Malignancy of Hepatocellular Carcinoma Development by Activating RhoA/YAP Signaling

SIMPLE SUMMARY: G protein–coupled receptors (GPCRs) are the most critical protein group for drug development, targeting about 35% of approved drugs. As their abnormal activation causes many diseases, including cancer, it is beneficial to discover novel GPCRs that are aberrantly expressed in cancer a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Yuna, Jung, Wonhee, Kim, Mi-Yeon, Shin, Dongjo, Kim, Geun Hee, Kim, Chun Ho, Park, Sun-Hoo, Cho, Eung-Ho, Choi, Dong Wook, Han, Chul Ju, Lee, Kee Ho, Kim, Sang-Bum, Shin, Hyun Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737590/
https://www.ncbi.nlm.nih.gov/pubmed/36497331
http://dx.doi.org/10.3390/cancers14235850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737590/
https://www.ncbi.nlm.nih.gov/pubmed/36497331
http://dx.doi.org/10.3390/cancers14235850

Ejemplares similares